Regulation of Memory T Cells by Interleukin-23

Size: px
Start display at page:

Download "Regulation of Memory T Cells by Interleukin-23"

Transcription

1 Review Published online: April 22, 2016 Regulation of Memory T Cells by Interleukin-23 Yanchun Li a Hongbo Wang a Honghua Lu b Shucheng Hua c a Division 1, Pediatric Respiratory Department, and Departments of b Children s Healthcare and c Respiratory Medicine, The First Hospital of Jilin University, Changchun, China Key Words Cytokine immunity Interleukins Memory T cell function Abstract Interleukin-23 (IL-23), a member of the IL-12 family of cytokines, is a heterodimeric cytokine. It is composed of subunits p40 (shared with IL-12) and p19 (an IL-12 p35-related subunit) and is secreted by several types of immune cells, such as natural killer cells and dendritic cells. The IL-23 receptor is composed of the subunit IL-12Rβ1 and the IL-23-specific subunit IL-23R. The binding of IL-23 to its specific cell surface receptor regulates a number of functions, including proliferation and differentiation of cells and secretion of cell factors. Memory T cells are a subset of T cells that secrete numerous important cell factors, and they function in the immune response to infection and diseases like cancer, autoimmune disease and bronchial asthma. IL-23R is expressed on the surface of s, which suggests that it can specifically regulate function. IL-23 has been widely used as a clinical indicator in immune-related diseases and shows potential for use in disease treatment. Here we review the current progress in the study of the role of IL-23 in the regulation of s S. Karger AG, Basel Introduction Cytokine immunity plays an essential role in the maintenance of health and in the development of clinical therapies [1, 2]. A great number of cytokines have been identified in humans, and their functions have been widely studied in animal models and human cells. Several cytokines have proved effective in the clinical treatment of specific diseases [3 7]. Understanding the molecular mechanism of cytokine function will help us better examine and treat different disease conditions. Immune cells, such as T cells, B cells and dendritic cells, play critical roles in cytokine immunity [1]. Among them, s are a subgroup of specific T cells that have previously encountered their cognate antigen (e.g. during a previous infection) and elicited a response [8]. Memory T cells have critical functions in the immunological response to infection and cancer [9]. The study of the regulation of function is thus a very promising area of research focused on the development of novel clinical treatments for inflammatory and infectious diseases as well as cancer. Interleukin-23 (IL-23) was discovered by Oppmann et al. [10] in Its receptor, IL-23R, was identified 2 years later [11]. Since then, the expression and functions of IL- 23 and its receptor have been extensively studied [12 14]. IL-23 has been used as a clinical indicator for a number of diseases, such as psoriasis and rheumatoid arthritis [15, 16], and has also been studied as a potential target for the karger@karger.com S. Karger AG, Basel /16/ $39.50/0 Correspondence to: Dr. Shucheng Hua Department of Respiratory Medicine The First Hospital of Jilin University Changchun (China) qq.com

2 development of clinical treatments for some of these diseases [17, 18]. Although several reviews have covered the functions of IL-23 [19, 20], here, we review the current progress in the study of its role in the regulation of memory T cells. Discovery of IL-23 In 2000, Oppmann et al. [10] searched DNA sequence databases with a computationally derived profile of members of the human IL-6 cytokine family, and identified a novel cytokine sequence which they called p19. p19 cdna (encoding a 189/196 amino acid polypeptide of 18.7/19.8 kda in humans and mice, respectively) shares 70% identity between human and mice and shows high protein similarity with the IL-12 p35 subunit [10]. Oppmann et al. [10] found that p19 required coexpression of the IL-12 p40 subunit to be secreted and biologically active, and named this heterodimeric cytokine IL-23. The main source of IL-23 is activated dendritic cells; IL-23 specifically functions on s [10]. In IL-23-deficient (p19 / ) mice, significantly low levels of antigen-specific IgG2a and IgA indicate a disruption of the humoral immunity [12]. Consistently, T cell-dependent, delayedtype hypersensitivity was significantly inhibited in these mice, indicating that the absence of IL-23p19 was associated with a reduction in the number of CD4+ memory T cells and a deficient immunological response [21]. These studies suggest that IL-23 plays a critical role in the regulation of function. Discovery of the IL-23 Receptor IL-23R was discovered in a screen for subunits that could interact with IL-23 p19 using IL-12β1-expressing BaF3 cells [11]. A polypeptide similar to IL-12β2 was identified that was able to form a heterodimeric receptor with IL-12β1 [11]. This polypeptide, named IL-23R, specifically interacts with IL-23, and its expression on the cell surface of specific cells defines the functional targets of IL-23 [11]. Human (h)il-23r is expressed in Th1 and Th0 cells as well as in a variety of natural killer cell lines [22]. Several types of monocytes and dendritic cells express extremely low levels of hil-23r. Epstein B virustreated B cells and anti-cd3/anti-cd28/lps-stimulated peripheral blood mononuclear cells also express relatively low but still detectable amounts of hil-23r mrna. The hil-23r expression pattern is similar to that of hil- 12Rβ2. On the other hand, mouse (m)il-23r is expressed in polarized Th1 and Th2 cells and bone marrow dendritic cells. However, the macrophage cell line J774 and several mast cell lines show no detectable expression of mil-23r mrna. The different expression patterns observed for IL-23R in human and mouse cell lines suggest that IL-23 may have unidentified dissimilar functions in humans and mice [11]. IL-23 is the main factor involved in the induction of differentiation of naïve T cells into Th17 cells. IL-23R is highly expressed in Th17 cells in both human and mice [23 26] In mice, memory (CD4+CD45RB low ) T cells express IL-23R mrna, but very low amounts of IL-12Rβ2. In contrast, naïve (CD4+CD45RB high ) T cells express IL- 12Rβ2, but show little or no IL-23R expression [11]. Similarly, human memory (CD4+CD45RA CD45RO+) T cells express IL-23R, but human naïve (CD4+ CD45RA+CD45RO ) T cells express very small amounts of IL-23R [27, 28]. These observations may explain why s respond to IL-23 treatment but show weak or no response to IL-12 treatment. On the other hand, naïve T cells show strong response to IL-12 treatment but no response to IL-23 treatment [22]. IL-23 Promotes Proliferation of Memory T Cells Oppmann et al. [10] reported that IL-23 could promote mouse proliferation. They used a p40-p35 fusion protein with similar activity to IL-12 to treat mouse naïve and s in vitro. They observed proliferation of naïve (CD4+CD45RB high ) T cells, but the s were not significantly stimulated. In contrast, when they used a Hy-p40-p19 fusion protein, with similar activity to IL-23, proliferation of memory (CD4+CD45RB low ) T cells, but not naïve T cells, was strongly induced. Moreover, an anti-il-12p40 neutralizing antibody decreased the effect of Hy-p40-p19 on memory T cells 100-fold. Consistently, addition of the supernatant from 293T cells cotransfected with p19 and p40 induced a similar proliferative response in mouse memory T cells to that promoted by p19-p40 fusion proteins [10]. Furthermore, in human s, Hy-p40- p19 promoted stronger proliferation of CD45RO+ T cells than CD45RA+ T cells, while IL-12 showed a similar effect on both CD45RO+ and CD45RA+ T cells [10]. Importantly, IL-23-mediated proliferation of memory T cells was dose-dependent [28]. Contrary to these observations, a study of IL-23R gene polymorphisms found that IL-23 could not promote proliferation of 158 Li/Wang/Lu/Hua

3 T cells in normal human peripheral blood in vitro [29]. It was also reported that cord blood naïve T cells could be polarized toward a Th17 phenotype upon IL-23 stimulation. The contradictory results of these studies may be attributable to the use of different doses of IL-23, cell activation methods and/or incubation times. Memory T cells hyperproliferate during disease; therefore, the role of IL-23 in the promotion of s may be important for the immunological response to certain diseases. For example, gastric cancer patients classified as stage I using the TMN cancer staging notation system showed higher levels of IL-23 in affected tissues than patients at TNM stages II, III and IV. Meanwhile, in gastric carcinoma, tumor-infiltrating lymphocytes, the number of memory CD4+ T cells and the proportion of effector s decreased at higher TNM stages. IL-23 levels were positively correlated with the number of effector s, suggesting that IL-23 promoted memory T cell proliferation in gastric cancer patients [30]. IL-23 Induces Memory T Cell Secretion of IL-17 Memory () T cells secrete IL-17 in normal peripheral blood after activation in vitro [31]. Addition of IL-23 alone to cultured memory (CD4+ CD45RO+) T cells induces a slight increase in IL-17 secretion [27]. However, when other factors, such as activating anti-cd3/anti-cd28, are added together with IL- 23, the level of IL-17 secreted from s significantly increases [23, 28, 29]. Consistently, intracellular IL-17 mrna levels significantly increase in these conditions [31]. Further analysis of s has shown that different subsets secrete diverse levels of IL- 17. After activation, memory (IL-23R+) T cells produce more IL-17A than IL-23R cells. IL-23R+ cells also express higher levels of IL-17A, IL-17F, IL-22, IL-26 and CCL20 mrna than IL-23R cells, as shown by real-time PCR [28]. These results support the notion that the interaction between IL- 23 and IL-23R is key for IL-23 function in s. Memory T cells can be further subdivided into central type memory (CCR7+) T cells (TCM) and effector memory (CCR7 ) T cells (TEM). TEM cells are the main source of IL-17, with levels of IL-17 secretion 4-fold higher than those of TCM cells. The addition of neutralizing antibodies against Th1 cytokine IFN-γ and Th2 cytokine IL-4 does not affect the amount of IL-17 secreted by s or the number of IL-17-producing cells [31]. TCM and TEM cells can be further divided into 2 subgroups according to the presence or absence of the CCR6 marker. In both CCR6+ and CCR6 TEM cells, IL-23 promotes IL-17 secretion. However, IL-23 does not promote IL-17 secretion in either CCR6+ or CCR6 TCM cells [31]. Three types of TEM cells have been described: those that secrete only IL-17, those that secrete IL-17 and IFN-γ and those secreting IL-17 and IL-22. IL-23 promotes the proliferation of all 3 CCR6+ TEM types 2-fold. In contrast, IL-23 is able to promote the proliferation of CCR6-TEM 6-fold. Naïve (CD4+CD45RA+) T cells do not normally secrete IL-17 and can only secrete very small amounts of IL-17 in the presence of IL-23 from dendritic cells [31, 32]. However, to mimic and induce the immune response, the addition of thymic stromal lymphopoietin and Tolllike receptor 3 ligand poly (I:C)-treated dendritic cells to naïve T cells for 7 days induces naïve (CD45RA+) T cells to differentiate into IL-17-secreting (CD45RA CD45RO+CD62L+CCR7+) TCM cells. Stimulation of these cells with anti-cd3 and anti-cd28 in the presence of IL-2 for 3 days induces them to display a (CD45RA CD45RO+CD62L low CCR7 low ) TEM phenotype. These results indicate that, in the presence of IL-23, naïve T cells can differentiate into Th17 s [33]. The effect of IL-23 on Th17 cell generation has also been observed in vivo [34, 35]. Although naïve T cells express low levels of IL-23R, the presence of IL-23 could increase the IL-23R expression level by simultaneous activation with anti-cd3 and anti-cd28. This effect could be inhibited by Th17 culture conditions (TGF-β1+ IL-6, anti-ifn-γ and anti-il-4); however, Th0 (neutral), Th1 (IL-12 and anti-il-4) and Th2 (IL-4, anti-il-12 and anti-ifn-γ) culture conditions did not affect the expression of IL-23R [27]. These studies strongly suggest a function for IL-23 in the regulation of IL-17 secretion. The induction of IL-17 secretion by IL- 23 has been observed in a number of diseases. In systemic sclerosis, the number of IL-17-secreting CD45RO+ and CD45RA+ cells is significantly increased, with the former expressing significantly higher levels of IL-17 than the latter, as shown by median fluorescence intensity detection, suggesting that the induction of IL-17 secretion by IL-23 is stronger in s [36]. In Behçet s disease associated with uveitis, a higher serum level and higher mrna expression level of IL-23 were observed. Additionally, recombinant IL-23 could increase the amount of IL-17 secreted from peripheral blood mononuclear cells in patients compared to healthy controls, suggesting that IL-23 may Function of IL-23 on Memory T Cells 159

4 Activating factors, e.g. TcR stimulus IL-23 Activating factors, e.g. TcR stimulus IL-23 ERK1/2 and p38 MAPK phosphorylation Color version available online Th2 cytokines: IL-4, IL-10 and IL-12R Moderate amount of IFN- No IFN- IFN- Fig. 1. s secrete IFN-γ. TcR = T cell receptor. promote the production of IL-17 by s in this disease [37]. In addition, IL-23 was able to promote IL-17 secretion by Th17 cells, which promotes the gathering of neutrophils to the airways during asthma [38]. IL-23 Induces Memory T Cell Secretion of IFN-γ In healthy people, activated memory () T cells secrete moderate amounts of IFN-γ ( fig. 1 ) [10]. While CCR7 TEM cells are the main IFN-γ-secreting cell population, TCM cells secrete low amounts of IFN-γ [31]. In the absence of anti-cd3 and anti-cd28 stimulation, neither Hy-p40-p19 nor IL-12 can induce secretion of IFN-γ in CD45RO+ T cells [10]. After the addition of activating factors, IL-23 can induce memory () T cells to secrete IFN-γ in a dose-dependent manner [22, 28, 29, 39]. After treatment with IL-23 for 3 days, CD45RO+ T cells secrete large amounts of IFN-γ [10]. Even though IL-23 can induce IFN-γ-secretion via both CD4+ and CD8+ memory T cells, its effect is more significant on CD4+ memory T cells than on CD8+ s. IL-23 induction of s to produce IFN-γ could be inhibited by the Th2 cytokines IL-4, IL-10 and IL-12Rβ1 [40]. Interestingly, phosphorylation of ERK1/2 and p38 MAPK is increased in dendritic cells concomitantly with the promotion of IFN-γ secretion by memory () T cells by IL-23, suggesting that these kinases are important signaling components of this pathway [41]. IL-23-mediated induction of IFN-γ secretion by s is also important in a number of diseases. IL-23 promotes the proliferation of CD4+ and CD4+ CD45RO+ cells in vitro and induces IFN-γ secretion more pronouncedly in cells from tuberculosis patients than in healthy cells. Mice infected with Schistosoma mansoni were found to exhibit Th1 immune response against SEA ( Schistosoma egg antigens) in CFA (complete Freund s adjuvant) and elevated the level of IFN-γ, which caused worse lesions. After infection with S. mansoni, IL-12p40 / mice, which cannot produce IL-23 and IL-12, were incapable of eliciting a pathological response. SEA-stimulated lymphocytes could not produce significant amounts of IFN-γ or IL-17. In contrast, SEA/CFAimmunized IL-12p35 / mice showed severely increased levels of IL-17 and IFN-γ, associated with the hyperproliferation of activated memory CD4+CD44 high / CD62L low T cells [42]. These results suggest that, in this animal model, IL-23 promoted the proliferation of memory CD4+ T cells that secreted high levels of IL-17 and IFN-γ, playing a catalytic role during inflammation and pathological changes. It should be noted that IL-23 is not the only factor capable of promoting IFN-γ secretion by s. In the presence of IL-2, IL-23R+ and IL- 23R T cells activated with anti-cd3, anti-cd28 and anti-cd2 produce large amounts of IFN-γ [28]. Even though Oppmann et al. [10] did not detect IFN-γ expression by CD45RA+ T cells stimulated with anti-cd3 and anti-cd28 antibodies, Liu and Rohowsky- 160 Li/Wang/Lu/Hua

5 Kochan [31] detected IFN-γ in cell supernatants from CD4+CD45RA+ T cells (which do not produce IFN-γ if not activated) after T cell receptor/anti-cd28 activation. Similarly, IL-12 significantly increased IFN-γ levels by activation of CD45RO+ T cells [10]. Furthermore, IL-23 promoted IFN-γ secretion not only in s but also in naïve T cells. CD45RA+ T cells secreted moderate amounts of IFN-γ 6 days after addition of IL-23 (in the absence of other activators), indicating that naïve T cells can respond to IL-23 after prolonged stimulation [10]. In addition to promoting IL-17 and IFN-γ secretion, IL-23 also functions in the production of other cell factors, such as GM-CSF in mice [43] and humans [44]. Activating factor, e.g. TcR stimulus Dose-dependent IL-23 Color version available online Cell proliferation Cytokine secretion: IL-17, IFN-, IL-22 IL-23 Clinical Applications The increase in the expression of IL-23R on the cell surface of s during the immunological response to some diseases suggests a specific role for IL-23 in disease response. For example, in patients with systemic sclerosis, CD3+, CD45RO+ and CD45RA+ cells in peripheral blood show increased levels of IL-23R [36]. In a number of diseases, s in the local lesion show higher levels of IL-23R than those in the circulating blood. In patients with arthritis, >95% of CD4+ T cells in the synovial fluid of local joints are memory CD45RO+ T cells. IL-23R-expressing T cells increase by 34.1%. In contrast, only 40% of CD4+ T cells are memory CD45RO+ T cells in the peripheral blood. The percentage of IL-23R-expressing CD4+ s is lower (33.3%) than that in synovial fluid [45], suggesting a role of IL-23 on s for local inflammation. Complexity arises when we consider IL-23R gene polymorphisms. These have been associated with changes in s numbers, proliferation and cytokine secretion [29]. R381Q (c.1142g>a; p.r381q) is one of the most studied IL23R gene polymorphisms and has been associated with a protective role in many inflammatory diseases. The effect of the R381Q IL23R gene polymorphism on memory CD4+ T cells can be summarized as follows: individuals carrying the R381Q IL23R gene polymorphism contain fewer s. Peripheral s (either R381Q or wild-type IL23R ) did not proliferate in vitro, regardless of IL-23 presence. Peripheral R381Q IL23R s secreted significantly lower amounts of both IL-17 and IL-22 in vitro after IL-23 administration and during allergen stimulation. However, IFN-γ secretion by R381Q IL23R s was not affected. Additionally, the presence of R381Q IL23R Fig. 2. The effect of IL-23 on s. TcR = T cell receptor. gene polymorphism has been associated with unresponsiveness to IL-23 by human memory Th17 cells, impairing the Th17 response in psoriasis patients [46]. One of the future challenges in the development of clinical applications for IL-23 will therefore be focused on overcoming the complexity of the interaction between IL- 23 and its receptor. Perspective Memory T cells play critical roles in a variety of diseases. IL-23 can promote the proliferation of memory T cells and the secretion of related cytokines ( fig. 2 ). IL-23 is thus likely to play a regulatory role in a number of diseases. Further validation and in-depth study of the mechanisms of IL-23 function in physiology and during disease will likely lead to the development of therapeutic approaches for the treatment of -associated inflammatory diseases and cancers. Acknowledgements This study was supported by a grant from the National Nature Science Foundation of China (No ). Disclosure Statement The authors declare there are no conflicts of interest. Function of IL-23 on Memory T Cells 161

6 References 1 Disis ML: Mechanism of action of immunotherapy. Semin Oncol 2014; 41(suppl 5):S3 S13. 2 Vinh DC: Cytokine immunomodulation for the treatment of infectious diseases: lessons from primary immunodeficiencies. Expert Rev Clin Immunol 2014; 10: Rosenberg SA: IL-2: the first effective immunotherapy for human cancer. J Immunol 2014; 192: Zarogoulidis P, et al: Interleukin-7 and interleukin-15 for cancer. J Cancer 2014; 5: Wang ZX, et al: Cytokine-induced killer cells in the treatment of patients with renal cell carcinoma: a pooled meta-analysis. Immunotherapy 2014; 6: Ni G, et al: Manipulating IL-10 signalling blockade for better immunotherapy. Cell Immunol 2015; 293: Davis MR, et al: The role of IL-21 in immunity and cancer. Cancer Lett 2015; 358: Rothenberg EV, Zhang J, Li L: Multilayered specification of the T-cell lineage fate. Immunol Rev 2010; 238: Farber DL, Yudanin NA, Restifo NP: Human s: generation, compartmentalization and homeostasis. Nat Rev Immunol 2014; 14: Oppmann B, et al: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13: Parham C, et al: A receptor for the heterodimeric cytokine IL-23 is composed of IL- 12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002; 168: Lankford CS, Frucht DM: A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 2003; 73: Beadling C, Slifka MK: Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27. Arch Immunol Ther Exp 2006; 54: Xu M, et al: Regulation of antitumor immune responses by the IL-12 family cytokines, IL- 12, IL-23, and IL-27. Clin Dev Immunol 2010; 2010:pii Fotiadou C, et al: IL-17A, IL-22, and IL-23 as markers of psoriasis activity: a cross-sectional, hospital-based study. J Cutan Med Surg 2015; 19: Wendling D, et al: Dysregulated serum IL-23 and SIRT1 activity in peripheral blood mononuclear cells of patients with rheumatoid arthritis. PLoS One 2015; 10:e Siebert S, et al: Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases. Pharmacol Rev 2015; 67: Mease PJ: Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis. Curr Opin Rheumatol 2015; 27: Boniface K, et al: From interleukin-23 to T- helper 17 cells: human T-helper cell differentiation revisited. Immunol Rev 2008; 226: Teng MW, et al: IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat Med 2015; 21: Ghilardi N, et al: Compromised humoral and delayed-type hypersensitivity responses in IL- 23-deficient mice. J Immunol 2004; 172: Trinchieri G, Pflanz S, Kastelein RA: The IL- 12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003; 19: Aggarwal S, et al: Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003; 278: Zhou L, et al: IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007; 8: Annunziato F, et al: Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204: Awasthi A, et al: Cutting edge: IL-23 receptor GFP reporter mice reveal distinct populations of IL-17-producing cells. J Immunol 2009; 182: Chen Z, et al: Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 2007; 56: Wilson NJ, et al: Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8: Sarin R, Wu X, Abraham C: Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proc Natl Acad Sci USA 2011; 108: Hu T, Wang H, Liu X, Zhang H, Dong M: Effects of IL-12 and IL-23 on CIM+ memory T cells in gastric carcinoma tissues. Chin J Anat 2009;32: Liu H, Rohowsky-Kochan C: Regulation of IL-17 in human CCR6+ effector memory T cells. J Immunol 2008; 180: Schirmer C, et al: Human fibroblasts support the expansion of IL-17-producing T cells via up-regulation of IL-23 production by dendritic cells. Blood 2010; 116: Tanaka J, et al: Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2- polarizing conditions. Clin Exp Allergy 2009; 39: Lee Y, et al: Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 2012; 13: Ghoreschi K, et al: Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 2010; 467: Radstake TR, et al: The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One 2009; 4:e Chi W, et al: Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci 2008; 49: Park SJ, Lee YC: Interleukin-17 regulation: an attractive therapeutic approach for asthma. Respir Res 2010; 11: Murphy KM, Reiner SL: The lineage decisions of helper T cells. Nat Rev Immunol 2002; 2: Fan Y, Wu C: Inhibitory effects of IL-4, IL-10, and anti-il-12rβ1 mabs on the production of IL-23-inducing IFN-γ by activated normal human s. Immunol J 2006;22: Jang MS, et al: Synergistic production of interleukin-23 by dendritic cells derived from cord blood in response to costimulation with LPS and IL-12. J Leukoc Biol 2009; 86: Rutitzky LI, Lopes da Rosa JR, Stadecker MJ: Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J Immunol 2005; 175: El-Behi M, et al: The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL- 23-induced production of the cytokine GM- CSF. Nat Immunol 2011; 12: Noster R, et al: IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells. Sci Transl Med 2014; 6: 241ra Andersen T, et al: Increased plasma levels of IL-21 and IL-23 in spondyloarthritis are not associated with clinical and MRI findings. Rheum Int 2012; 32: Di Meglio P, et al: The IL23R A/Gln381 allele promotes IL-23 unresponsiveness in human memory T-helper 17 cells and impairs Th17 responses in psoriasis patients. J Invest Dermatol 2013; 133: Li/Wang/Lu/Hua

IL-17 in health and disease. March 2014 PSO13-C051n

IL-17 in health and disease. March 2014 PSO13-C051n IL-17 in health and disease March 2014 PSO13-C051n Originally Researchers Suggested That IL-12 and IL-4 drove Th Cell Differentiation Naïve CD4 + T cell Question: Which of these cell types is responsible

More information

DNA vaccine, peripheral T-cell tolerance modulation 185

DNA vaccine, peripheral T-cell tolerance modulation 185 Subject Index Airway hyperresponsiveness (AHR) animal models 41 43 asthma inhibition 45 overview 41 mast cell modulation of T-cells 62 64 respiratory tolerance 40, 41 Tregs inhibition role 44 respiratory

More information

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS Choompone Sakonwasun, MD (Hons), FRCPT Types of Adaptive Immunity Types of T Cell-mediated Immune Reactions CTLs = cytotoxic T lymphocytes

More information

Effector T Cells and

Effector T Cells and 1 Effector T Cells and Cytokines Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School 2 Lecture outline Cytokines Subsets of CD4+ T cells: definitions, functions, development New

More information

Adaptive immune responses: T cell-mediated immunity

Adaptive immune responses: T cell-mediated immunity MICR2209 Adaptive immune responses: T cell-mediated immunity Dr Allison Imrie allison.imrie@uwa.edu.au 1 Synopsis: In this lecture we will discuss the T-cell mediated immune response, how it is activated,

More information

Central tolerance. Mechanisms of Immune Tolerance. Regulation of the T cell response

Central tolerance. Mechanisms of Immune Tolerance. Regulation of the T cell response Immunoregulation: A balance between activation and suppression that achieves an efficient immune response without damaging the host. Mechanisms of Immune Tolerance ACTIVATION (immunity) SUPPRESSION (tolerance)

More information

Mechanisms of Immune Tolerance

Mechanisms of Immune Tolerance Immunoregulation: A balance between activation and suppression that achieves an efficient immune response without damaging the host. ACTIVATION (immunity) SUPPRESSION (tolerance) Autoimmunity Immunodeficiency

More information

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION Scott Abrams, Ph.D. Professor of Oncology, x4375 scott.abrams@roswellpark.org Kuby Immunology SEVENTH EDITION CHAPTER 11 T-Cell Activation, Differentiation, and Memory Copyright 2013 by W. H. Freeman and

More information

Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells

Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells ICI Basic Immunology course Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells Abul K. Abbas, MD UCSF Stages in the development of T cell responses: induction

More information

Autoimmune Diseases. Betsy Kirchner CNP The Cleveland Clinic

Autoimmune Diseases. Betsy Kirchner CNP The Cleveland Clinic Autoimmune Diseases Betsy Kirchner CNP The Cleveland Clinic Disclosures (financial) No relevant disclosures Learning Objectives Explain the pathophysiology of autoimmune disease Discuss safe administration

More information

Cellular Immune response. Jianzhong Chen, Ph.D Institute of immunology, ZJU

Cellular Immune response. Jianzhong Chen, Ph.D Institute of immunology, ZJU Cellular Immune response Jianzhong Chen, Ph.D Institute of immunology, ZJU Concept of adaptive immune response T cell-mediated adaptive immune response I. Concept of immune response A collective and coordinated

More information

Determinants of Immunogenicity and Tolerance. Abul K. Abbas, MD Department of Pathology University of California San Francisco

Determinants of Immunogenicity and Tolerance. Abul K. Abbas, MD Department of Pathology University of California San Francisco Determinants of Immunogenicity and Tolerance Abul K. Abbas, MD Department of Pathology University of California San Francisco EIP Symposium Feb 2016 Why do some people respond to therapeutic proteins?

More information

Following T-cell activation and differentiation with HTRF reagents: IL-2, IFN-γ and IL-17

Following T-cell activation and differentiation with HTRF reagents: IL-2, IFN-γ and IL-17 Following T-cell activation and differentiation with HTRF reagents: IL-2, IFN-γ and IL-17 4 th HTRF Symposium for Drug Discovery Avignon, Sept. 24-26, 28 Introduction: T-cells have effector and helper

More information

Analysis of regulatory T cell subsets in the peripheral blood of immunoglobulin A nephropathy (IgAN) patients

Analysis of regulatory T cell subsets in the peripheral blood of immunoglobulin A nephropathy (IgAN) patients Analysis of regulatory T cell subsets in the peripheral blood of immunoglobulin A nephropathy (IgAN) patients S. Yang, B. Chen, J. Shi, F. Chen, J. Zhang and Z. Sun Department of Nephrology, Huaihe Hospital

More information

Biology of Immune Aging

Biology of Immune Aging Biology of Immune Aging Jorg J. Goronzy Stanford University Immune deficiency Increase morbidity and mortality from infections Poor vaccine responses Cancer Immune Aging Chronic inflammation Coronary artery

More information

Cytokines modulate the functional activities of individual cells and tissues both under normal and pathologic conditions Interleukins,

Cytokines modulate the functional activities of individual cells and tissues both under normal and pathologic conditions Interleukins, Cytokines http://highered.mcgraw-hill.com/sites/0072507470/student_view0/chapter22/animation the_immune_response.html Cytokines modulate the functional activities of individual cells and tissues both under

More information

Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF

Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases Abul K. Abbas UCSF Balancing lymphocyte activation and control Activation Effector T cells Tolerance Regulatory T cells

More information

Examples of questions for Cellular Immunology/Cellular Biology and Immunology

Examples of questions for Cellular Immunology/Cellular Biology and Immunology Examples of questions for Cellular Immunology/Cellular Biology and Immunology Each student gets a set of 6 questions, so that each set contains different types of questions and that the set of questions

More information

Relevant Disclosures

Relevant Disclosures 6/18/215 Therapeutic developments for autoimmune demyelinating diseases: Musings from a MD (Mouse Doctor) Michael K. Racke, M.D. May 28, 215 Relevant Disclosures Editorial Boards for Journal of Neuroimmunology,

More information

General Overview of Immunology. Kimberly S. Schluns, Ph.D. Associate Professor Department of Immunology UT MD Anderson Cancer Center

General Overview of Immunology. Kimberly S. Schluns, Ph.D. Associate Professor Department of Immunology UT MD Anderson Cancer Center General Overview of Immunology Kimberly S. Schluns, Ph.D. Associate Professor Department of Immunology UT MD Anderson Cancer Center Objectives Describe differences between innate and adaptive immune responses

More information

Immune response to infection

Immune response to infection Immune response to infection Dr. Sandra Nitsche (Sandra.Nitsche@rub.de ) 20.06.2018 1 Course of acute infection Typical acute infection that is cleared by an adaptive immune reaction 1. invasion of pathogen

More information

Mechanisms of allergen-specific immunotherapy

Mechanisms of allergen-specific immunotherapy 2012 KAAACI/EAAS Spring Mechanisms of allergen-specific immunotherapy Woo-Jung Song, MD Division of Allergy and Clinical Immunology Department of Internal Medicine Seoul National University Hospital, Seoul,

More information

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS 1 Antigen Presentation and T Lymphocyte Activation Abul K. Abbas UCSF FOCiS 2 Lecture outline Dendritic cells and antigen presentation The role of the MHC T cell activation Costimulation, the B7:CD28 family

More information

ECM1 controls T H 2 cell egress from lymph nodes through re-expression of S1P 1

ECM1 controls T H 2 cell egress from lymph nodes through re-expression of S1P 1 ZH, Li et al, page 1 ECM1 controls T H 2 cell egress from lymph nodes through re-expression of S1P 1 Zhenhu Li 1,4,Yuan Zhang 1,4, Zhiduo Liu 1, Xiaodong Wu 1, Yuhan Zheng 1, Zhiyun Tao 1, Kairui Mao 1,

More information

NIH Public Access Author Manuscript J Invest Dermatol. Author manuscript; available in PMC 2015 February 01.

NIH Public Access Author Manuscript J Invest Dermatol. Author manuscript; available in PMC 2015 February 01. NIH Public Access Author Manuscript Published in final edited form as: J Invest Dermatol. 2014 August ; 134(8): 2071 2074. doi:10.1038/jid.2014.141. A possible role for IL-17A in establishing Th2 inflammation

More information

Basis of Immunology and

Basis of Immunology and Basis of Immunology and Immunophysiopathology of Infectious Diseases Jointly organized by Institut Pasteur in Ho Chi Minh City and Institut Pasteur with kind support from ANRS & Université Pierre et Marie

More information

The Adaptive Immune Responses

The Adaptive Immune Responses The Adaptive Immune Responses The two arms of the immune responses are; 1) the cell mediated, and 2) the humoral responses. In this chapter we will discuss the two responses in detail and we will start

More information

Adaptive Immunity. Jeffrey K. Actor, Ph.D. MSB 2.214,

Adaptive Immunity. Jeffrey K. Actor, Ph.D. MSB 2.214, Adaptive Immunity Jeffrey K. Actor, Ph.D. MSB 2.214, 500-5344 Lecture Objectives: Understand role of various molecules including cytokines, chemokines, costimulatory and adhesion molecules in the development

More information

T Cell Effector Mechanisms I: B cell Help & DTH

T Cell Effector Mechanisms I: B cell Help & DTH T Cell Effector Mechanisms I: B cell Help & DTH Ned Braunstein, MD The Major T Cell Subsets p56 lck + T cells γ δ ε ζ ζ p56 lck CD8+ T cells γ δ ε ζ ζ Cα Cβ Vα Vβ CD3 CD8 Cα Cβ Vα Vβ CD3 MHC II peptide

More information

Chapter 13: Cytokines

Chapter 13: Cytokines Chapter 13: Cytokines Definition: secreted, low-molecular-weight proteins that regulate the nature, intensity and duration of the immune response by exerting a variety of effects on lymphocytes and/or

More information

Principles of Adaptive Immunity

Principles of Adaptive Immunity Principles of Adaptive Immunity Chapter 3 Parham Hans de Haard 17 th of May 2010 Agenda Recognition molecules of adaptive immune system Features adaptive immune system Immunoglobulins and T-cell receptors

More information

Immunology for the Rheumatologist

Immunology for the Rheumatologist Immunology for the Rheumatologist Rheumatologists frequently deal with the immune system gone awry, rarely studying normal immunology. This program is an overview and discussion of the function of the

More information

Part III Innate and Adaptive Immune Cells: General Introduction

Part III Innate and Adaptive Immune Cells: General Introduction Innate and Adaptive Immune Cells: General Introduction Iván López-Expósito As an organ specialized in food digestion and nutrient absorption, the intestinal mucosa presents a huge surface area (almost

More information

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes: Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,

More information

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes: Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,

More information

Abstract. IgE. IgE Th2. x x IL-4 IL-5 IgE CD4 +

Abstract. IgE. IgE Th2. x x IL-4 IL-5 IgE CD4 + D. o ƒf 6,''!" # + % %$ '& ' '' & " k n k x k k k k k x k IgE k x IgE Ò1Ó k Ò2Ó v k x IgE Th2 x } x x IL-4 IL-5 IgE IgE j IFN-γ IgG j j CD4 + { k d «d j B7 w k k x IgE k 1 k Abstract Parental immunization

More information

Cell-mediated Immunity

Cell-mediated Immunity Cellular & Molecular Immunology Cell-mediated Immunity Nicholas M. Ponzio, Ph.D. Department of Pathology & Laboratory Medicine April 6, 2009 Today s Presentation: Overview Cellular Interactions In Humoral

More information

Th17 Pathway Research By Bio-Plex

Th17 Pathway Research By Bio-Plex Th17 Pathway Research By Bio-Plex Zhiyang Shen, Senior Product Manager Bio-Rad Laboratories, Inc 2011 年 6 月 28 日星期二 T helper cell research Timeline: advances on T helper research. Figure depicts some of

More information

Immunology. T-Lymphocytes. 16. Oktober 2014, Ruhr-Universität Bochum Karin Peters,

Immunology. T-Lymphocytes. 16. Oktober 2014, Ruhr-Universität Bochum Karin Peters, Immunology T-Lymphocytes 16. Oktober 2014, Ruhr-Universität Bochum Karin Peters, karin.peters@rub.de The role of T-effector cells in the immune response against microbes cellular immunity humoral immunity

More information

New insights into CD8+ T cell function and regulation. Pam Ohashi Princess Margaret Cancer Centre

New insights into CD8+ T cell function and regulation. Pam Ohashi Princess Margaret Cancer Centre New insights into CD8+ T cell function and regulation Pam Ohashi Princess Margaret Cancer Centre New insights into CD8+ T cell function and regulation Pam Ohashi Princess Margaret Cancer Centre No Disclosures

More information

Manuscript: OX40 signaling is involved in the autoactivation of CD4 + CD28 - T cells and contributes to pathogenesis of autoimmune arthritis

Manuscript: OX40 signaling is involved in the autoactivation of CD4 + CD28 - T cells and contributes to pathogenesis of autoimmune arthritis Manuscript: OX40 signaling is involved in the autoactivation of CD4 + CD28 - T cells and contributes to pathogenesis of autoimmune arthritis Vincent Laufer Rheumatology JC October 17 Disclosures NIH 2

More information

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION Scott Abrams, Ph.D. Professor of Oncology, x4375 scott.abrams@roswellpark.org Kuby Immunology SEVENTH EDITION CHAPTER 13 Effector Responses: Cell- and Antibody-Mediated Immunity Copyright 2013 by W. H.

More information

Immunity and Cancer. Doriana Fruci. Lab di Immuno-Oncologia

Immunity and Cancer. Doriana Fruci. Lab di Immuno-Oncologia Immunity and Cancer Doriana Fruci Lab di Immuno-Oncologia Immune System is a network of cells, tissues and organs that work together to defend the body against attacks of foreign invaders (pathogens, cancer

More information

Immunology MIMM-314 MID-TERM II EXAMINATION. 1 hour between 8:30 a.m. - 10:00 a.m. McIntyre Medical Rm 504 (Martin Amphitheatre)

Immunology MIMM-314 MID-TERM II EXAMINATION. 1 hour between 8:30 a.m. - 10:00 a.m. McIntyre Medical Rm 504 (Martin Amphitheatre) GROUP (Version) 1 Annotated version April 8, 2011, RGEP DEPARTMENT OF MICROBIOLOGY AND IMMUNOLOGY Immunology MIMM-314 MID-TERM II EXAMINATION Course Coordinator: Dr. Roger Palfree Date: Thursday, March

More information

Test Bank for Basic Immunology Functions and Disorders of the Immune System 4th Edition by Abbas

Test Bank for Basic Immunology Functions and Disorders of the Immune System 4th Edition by Abbas Test Bank for Basic Immunology Functions and Disorders of the Immune System 4th Edition by Abbas Chapter 04: Antigen Recognition in the Adaptive Immune System Test Bank MULTIPLE CHOICE 1. Most T lymphocytes

More information

Role of BAFF in B cell Biology and Autoimmunity

Role of BAFF in B cell Biology and Autoimmunity Role of BAFF in B cell Biology and Autoimmunity B cell development in health and disease: B-lymphocytes or B cells, and the antibodies they produce, are crucial mediators of humoral immunity, providing

More information

T cell and Cell-mediated immunity

T cell and Cell-mediated immunity T cell and Cell-mediated immunity ( 第十章 第十二章第十二章 ) Lu Linrong ( 鲁林荣 ) PhD Laboratory of Immune Regulation Institute of Immunology Zhejiang University, School of Medicine Medical Research Building B815-819

More information

Naive, memory and regulatory T lymphocytes populations analysis

Naive, memory and regulatory T lymphocytes populations analysis Naive, memory and regulatory T lymphocytes populations analysis Jaen Olivier, PhD ojaen@beckmancoulter.com Cellular Analysis application specialist Beckman Coulter France Introduction Flow cytometric analysis

More information

Oncolytic Immunotherapy: A Local and Systemic Antitumor Approach

Oncolytic Immunotherapy: A Local and Systemic Antitumor Approach Oncolytic Immunotherapy: A Local and Systemic Antitumor Approach Oncolytic immunotherapy Oncolytic immunotherapy the use of a genetically modified virus to attack tumors and induce a systemic immune response

More information

Attribution: University of Michigan Medical School, Department of Microbiology and Immunology

Attribution: University of Michigan Medical School, Department of Microbiology and Immunology Attribution: University of Michigan Medical School, Department of Microbiology and Immunology License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution

More information

Innate Immunity II. Integration. Lindsay Nicholson Advanced Immunology L2

Innate Immunity II. Integration. Lindsay Nicholson Advanced Immunology L2 Innate Immunity II Integration Lindsay Nicholson Advanced Immunology L2 l.nicholson@bristol.ac.uk Lecture 1 Defining Innate Immunity Recognition and effector mechanisms (I) Lecture 2 Recognition and effector

More information

T cell-mediated immunity

T cell-mediated immunity T cell-mediated immunity Overview For microbes within phagosomes in phagocytes.cd4+ T lymphocytes (TH1) Activate phagocyte by cytokines studies on Listeria monocytogenes For microbes infecting and replicating

More information

Darwinian selection and Newtonian physics wrapped up in systems biology

Darwinian selection and Newtonian physics wrapped up in systems biology Darwinian selection and Newtonian physics wrapped up in systems biology Concept published in 1957* by Macfarland Burnet (1960 Nobel Laureate for the theory of induced immune tolerance, leading to solid

More information

Lecture outline. Immunological tolerance and immune regulation. Central and peripheral tolerance. Inhibitory receptors of T cells. Regulatory T cells

Lecture outline. Immunological tolerance and immune regulation. Central and peripheral tolerance. Inhibitory receptors of T cells. Regulatory T cells 1 Immunological tolerance and immune regulation Abul K. Abbas UCSF 2 Lecture outline Central and peripheral tolerance Inhibitory receptors of T cells Regulatory T cells 1 The immunological equilibrium:

More information

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Medical Virology Immunology Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Human blood cells Phases of immune responses Microbe Naïve

More information

Primer on Tumor Immunology. International Society for Biological Therapy of Cancer. C. H. June, M.D. November 10, 2005

Primer on Tumor Immunology. International Society for Biological Therapy of Cancer. C. H. June, M.D. November 10, 2005 Primer on Tumor Immunology International Society for Biological Therapy of Cancer C. H. June, M.D. November 10, 2005 Outline: Primer on Tumor Immunology T Cell Receptors T Cell Biology Tumor immunology

More information

Immune Regulation and Tolerance

Immune Regulation and Tolerance Immune Regulation and Tolerance Immunoregulation: A balance between activation and suppression of effector cells to achieve an efficient immune response without damaging the host. Activation (immunity)

More information

The Adaptive Immune Response. T-cells

The Adaptive Immune Response. T-cells The Adaptive Immune Response T-cells T Lymphocytes T lymphocytes develop from precursors in the thymus. Mature T cells are found in the blood, where they constitute 60% to 70% of lymphocytes, and in T-cell

More information

Putting it Together. Stephen Canfield Secondary Lymphoid System. Tonsil Anterior Cervical LN s

Putting it Together. Stephen Canfield Secondary Lymphoid System. Tonsil Anterior Cervical LN s Putting it Together Stephen Canfield smc12@columbia.edu Secondary Lymphoid System Tonsil Anterior Cervical LN s Axillary LN s Mediastinal/Retroperitoneal LN s Thoracic Duct Appendix Spleen Inguinal LN

More information

Innate immune regulation of T-helper (Th) cell homeostasis in the intestine

Innate immune regulation of T-helper (Th) cell homeostasis in the intestine Innate immune regulation of T-helper (Th) cell homeostasis in the intestine Masayuki Fukata, MD, Ph.D. Research Scientist II Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation,

More information

E-1 Role of IgE and IgE receptors in allergic airway inflammation and remodeling

E-1 Role of IgE and IgE receptors in allergic airway inflammation and remodeling E-1 Role of IgE and IgE receptors in allergic airway inflammation and remodeling Ruby Pawankar, MD, Ph.D. FRCP, FAAAAI Prof. Div of Allergy, Dept of Pediatrics Nippon Medical School Tokyo, Japan pawankar.ruby@gmail.com

More information

The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23- induced production of the cytokine GM-CSF

The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23- induced production of the cytokine GM-CSF CORRECTION NOTICE Nat.Immunol. 12, 568 575 (2011) The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23- induced production of the cytokine GM-CSF Mohamed El-Behi, Bogoljub Ciric, Hong

More information

The Adaptive Immune Response. B-cells

The Adaptive Immune Response. B-cells The Adaptive Immune Response B-cells The innate immune system provides immediate protection. The adaptive response takes time to develop and is antigen specific. Activation of B and T lymphocytes Naive

More information

Tolerance 2. Regulatory T cells; why tolerance fails. FOCiS. Lecture outline. Regulatory T cells. Regulatory T cells: functions and clinical relevance

Tolerance 2. Regulatory T cells; why tolerance fails. FOCiS. Lecture outline. Regulatory T cells. Regulatory T cells: functions and clinical relevance 1 Tolerance 2. Regulatory T cells; why tolerance fails Abul K. Abbas UCSF FOCiS 2 Lecture outline Regulatory T cells: functions and clinical relevance Pathogenesis of autoimmunity: why selftolerance fails

More information

1. Overview of Adaptive Immunity

1. Overview of Adaptive Immunity Chapter 17A: Adaptive Immunity Part I 1. Overview of Adaptive Immunity 2. T and B Cell Production 3. Antigens & Antigen Presentation 4. Helper T cells 1. Overview of Adaptive Immunity The Nature of Adaptive

More information

Chapter 1. Chapter 1 Concepts. MCMP422 Immunology and Biologics Immunology is important personally and professionally!

Chapter 1. Chapter 1 Concepts. MCMP422 Immunology and Biologics Immunology is important personally and professionally! MCMP422 Immunology and Biologics Immunology is important personally and professionally! Learn the language - use the glossary and index RNR - Reading, Note taking, Reviewing All materials in Chapters 1-3

More information

Tolerance 2. Regulatory T cells; why tolerance fails. Abul K. Abbas UCSF. FOCiS

Tolerance 2. Regulatory T cells; why tolerance fails. Abul K. Abbas UCSF. FOCiS 1 Tolerance 2. Regulatory T cells; why tolerance fails Abul K. Abbas UCSF FOCiS 2 Lecture outline Regulatory T cells: functions and clinical relevance Pathogenesis of autoimmunity: why selftolerance fails

More information

Basis and Clinical Applications of Interferon

Basis and Clinical Applications of Interferon Interferon Therapy Basis and Clinical Applications of Interferon JMAJ 47(1): 7 12, 2004 Jiro IMANISHI Professor, Kyoto Prefectural University of Medicine Abstract: Interferon (IFN) is an antiviral substance

More information

The Lymphatic System and Body Defenses

The Lymphatic System and Body Defenses PowerPoint Lecture Slide Presentation by Patty Bostwick-Taylor, Florence-Darlington Technical College The Lymphatic System and Body Defenses 12PART B Adaptive Defense System: Third Line of Defense Immune

More information

Regulation of anti-tumor immunity through migration of immune cell subsets within the tumor microenvironment Thomas F. Gajewski, M.D., Ph.D.

Regulation of anti-tumor immunity through migration of immune cell subsets within the tumor microenvironment Thomas F. Gajewski, M.D., Ph.D. Regulation of anti-tumor immunity through migration of immune cell subsets within the tumor microenvironment Thomas F. Gajewski, M.D., Ph.D. Professor, Departments of Pathology and Medicine Program Leader,

More information

Adaptive Immune System

Adaptive Immune System Short Course on Immunology Adaptive Immune System Bhargavi Duvvuri Ph.D IIIrd Year (Immunology) bhargavi@yorku.ca Supervisor Dr.Gillian E Wu Professor, School of Kinesiology and Health Sciences York University,

More information

T Lymphocyte Activation and Costimulation. FOCiS. Lecture outline

T Lymphocyte Activation and Costimulation. FOCiS. Lecture outline 1 T Lymphocyte Activation and Costimulation Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline T cell activation Costimulation, the B7:CD28 family Inhibitory receptors of T cells Targeting costimulators for

More information

9607 Dr. Perry Road Suite 103. Ijamsville, MD Tel: (301) Fax: (301) Ultrasensitive Samoa Human IL-33 Immunoassay

9607 Dr. Perry Road Suite 103. Ijamsville, MD Tel: (301) Fax: (301) Ultrasensitive Samoa Human IL-33 Immunoassay AssayGate, Inc. 9607 Dr. Perry Road Suite 103. Ijamsville, MD 21754. Tel: (301)874-0988. Fax: (301)560-8288. Ultrasensitive Samoa Human IL-33 Immunoassay INTRODUCTION Interleukin-33 (IL-33), a cytokine

More information

Immunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine

Immunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine Immunology of Asthma Kenneth J. Goodrum,Ph Ph.D. Ohio University College of Osteopathic Medicine Outline Consensus characteristics/incidence data Immune/inflammatory basis Etiology/Genetic basis Hygiene

More information

Immunopathogenesis of SLE and Rationale for Biologic Therapy

Immunopathogenesis of SLE and Rationale for Biologic Therapy Immunopathogenesis of SLE and Rationale for Biologic Therapy Peter Lipsky, MD Editor, Arthritis Research and Therapy Bethesda, MD Environmental Triggers, Gender, and Genetic Factors Contribute to SLE Pathogenesis

More information

Immune System. Presented by Kazzandra Anton, Rhea Chung, Lea Sado, and Raymond Tanaka

Immune System. Presented by Kazzandra Anton, Rhea Chung, Lea Sado, and Raymond Tanaka Immune System Presented by Kazzandra Anton, Rhea Chung, Lea Sado, and Raymond Tanaka Content Standards 35.1 In innate immunity, recognition and response rely on traits common to groups of pathogens 35.2

More information

Parallel session IVB. Chair: Hans Wildiers

Parallel session IVB. Chair: Hans Wildiers Parallel session IVB Biology of ageing and cancer Chair: Hans Wildiers IMMUNOSENESCENCE AND AGEING Tamas Fulop M.D., PhD Research Center on Aging, Division of Geriatrics, University of Sherbrooke, Sherbrooke,

More information

IMMUNOTHERAPY FOR CANCER A NEW HORIZON. Ekaterini Boleti MD, PhD, FRCP Consultant in Medical Oncology Royal Free London NHS Foundation Trust

IMMUNOTHERAPY FOR CANCER A NEW HORIZON. Ekaterini Boleti MD, PhD, FRCP Consultant in Medical Oncology Royal Free London NHS Foundation Trust IMMUNOTHERAPY FOR CANCER A NEW HORIZON Ekaterini Boleti MD, PhD, FRCP Consultant in Medical Oncology Royal Free London NHS Foundation Trust ASCO Names Advance of the Year: Cancer Immunotherapy No recent

More information

Immunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells

Immunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells Immunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells Andrew H. Lichtman, M.D. Ph.D. Department of Pathology Brigham and Women s Hospital and Harvard

More information

Is it CVID? Not Necessarily HAIG TCHEUREKDJIAN, MD

Is it CVID? Not Necessarily HAIG TCHEUREKDJIAN, MD Is it CVID? Not Necessarily HAIG TCHEUREKDJIAN, MD Current Paradigm of Pathogenesis Genetic defect(s) Molecular defect(s) Cellular defect(s) Clinical disease Current Paradigm of Pathogenesis Genetic defect(s)

More information

T Cell Activation, Costimulation and Regulation

T Cell Activation, Costimulation and Regulation 1 T Cell Activation, Costimulation and Regulation Abul K. Abbas, MD University of California San Francisco 2 Lecture outline T cell antigen recognition and activation Costimulation, the B7:CD28 family

More information

Intracellular MHC class II molecules promote TLR-triggered innate. immune responses by maintaining Btk activation

Intracellular MHC class II molecules promote TLR-triggered innate. immune responses by maintaining Btk activation Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining Btk activation Xingguang Liu, Zhenzhen Zhan, Dong Li, Li Xu, Feng Ma, Peng Zhang, Hangping Yao and Xuetao

More information

Additional file 6. Summary of experiments characterizing development of adaptive immune response

Additional file 6. Summary of experiments characterizing development of adaptive immune response Additional file 6. Summary of experiments characterizing development of adaptive immune response Tests performed to evaluate the development of adaptive immunity in patients are summarized in Table 1.

More information

Helminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii. Ringworm fungus HIV Influenza

Helminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii. Ringworm fungus HIV Influenza Helminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii Ringworm fungus HIV Influenza Candida Staph aureus Mycobacterium tuberculosis Listeria Salmonella Streptococcus Levels

More information

DISCOVER MORE WITH LESS SAMPLE. nanostring.com/3d

DISCOVER MORE WITH LESS SAMPLE. nanostring.com/3d nanostring.com/3d DISCOVER MORE WITH LESS SAMPLE. WHY COMPROMISE? ncounter Vantage ASSAYS POWERED BY 3D BIOLOGY TECHNOLOGY Don t let sample volume limit your analytical aspirations. Quantify DNA, RNA,

More information

Allergy and Immunology Review Corner: Chapter 1 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti.

Allergy and Immunology Review Corner: Chapter 1 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti. Allergy and Immunology Review Corner: Chapter 1 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti. Chapter 1: Overview of Immunology Prepared by David Scott, MD, Scripps

More information

The Skinny of the Immune System

The Skinny of the Immune System The Skinny of the Immune System Robert Hostoffer, DO, FACOP, FAAP Associate Professor of Pediatrics Case Western Reserve University, Cleveland, Ohio Overview 1. Immune system of the skin 2. Immune Players

More information

The development of T cells in the thymus

The development of T cells in the thymus T cells rearrange their receptors in the thymus whereas B cells do so in the bone marrow. The development of T cells in the thymus The lobular/cellular organization of the thymus Immature cells are called

More information

T cell maturation. T-cell Maturation. What allows T cell maturation?

T cell maturation. T-cell Maturation. What allows T cell maturation? T-cell Maturation What allows T cell maturation? Direct contact with thymic epithelial cells Influence of thymic hormones Growth factors (cytokines, CSF) T cell maturation T cell progenitor DN DP SP 2ry

More information

USTEKINUMAB and BRIAKINUMAB

USTEKINUMAB and BRIAKINUMAB USTEKINUMAB and BRIAKINUMAB Andrew Blauvelt, M.D. Professor, Dept. of Dermatology and Dept. of Molecular Microbiology & Immunology Oregon Health & Science University Chief, Dermatology Service Veteran

More information

Immunology and Immunotherapy 101 for the Non-Immunologist

Immunology and Immunotherapy 101 for the Non-Immunologist Immunology and Immunotherapy 101 for the Non-Immunologist Stephen P. Schoenberger, Ph.D La Jolla Institute for Allergy and Immunology & UCSD Moores Cancer Center Disclosures Human Longevity Inc: Salary

More information

Immunological Tolerance

Immunological Tolerance Immunological Tolerance Introduction Definition: Unresponsiveness to an antigen that is induced by exposure to that antigen Tolerogen = tolerogenic antigen = antigen that induces tolerance Important for

More information

CHAPTER I INTRODUCTION. for both infectious diseases and malignancies. Immunity is known as the innate

CHAPTER I INTRODUCTION. for both infectious diseases and malignancies. Immunity is known as the innate CHAPTER I INTRODUCTION 1.1. Background of Study The immune system s function is to provide defense of the human body for both infectious diseases and malignancies. Immunity is known as the innate immunity

More information

Enhancing the Clinical Activity of HER2/neu Specific T Cells. William Gwin, MD Internal Medicine, Resident University of Washington

Enhancing the Clinical Activity of HER2/neu Specific T Cells. William Gwin, MD Internal Medicine, Resident University of Washington Enhancing the Clinical Activity of HER2/neu Specific T Cells William Gwin, MD Internal Medicine, Resident University of Washington Immunotherapy and Cancer Cancer vaccines were originally used in melanoma

More information

All animals have innate immunity, a defense active immediately upon infection Vertebrates also have adaptive immunity

All animals have innate immunity, a defense active immediately upon infection Vertebrates also have adaptive immunity 1 2 3 4 5 6 7 8 9 The Immune System All animals have innate immunity, a defense active immediately upon infection Vertebrates also have adaptive immunity Figure 43.2 In innate immunity, recognition and

More information

Immune Tolerance. Kyeong Cheon Jung. Department of Pathology Seoul National University College of Medicine

Immune Tolerance. Kyeong Cheon Jung. Department of Pathology Seoul National University College of Medicine Immune Tolerance Kyeong Cheon Jung Department of Pathology Seoul National University College of Medicine Immune tolerance Unresponsiveness to an antigen that is induced by previous exposure to that antigen

More information

Toll-like Receptors (TLRs): Biology, Pathology and Therapeutics

Toll-like Receptors (TLRs): Biology, Pathology and Therapeutics Toll-like Receptors (TLRs): Biology, Pathology and Therapeutics Dr Sarah Sasson SydPATH Registrar 23 rd June 2014 TLRs: Introduction Discovered in 1990s Recognise conserved structures in pathogens Rely

More information

Chapter 7 Conclusions

Chapter 7 Conclusions VII-1 Chapter 7 Conclusions VII-2 The development of cell-based therapies ranging from well-established practices such as bone marrow transplant to next-generation strategies such as adoptive T-cell therapy

More information

Autoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens

Autoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens Autoimmunity Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens Autoimmune disease can be caused to primary defects in B cells, T cells and possibly

More information

Supplemental Figure 1. Signature gene expression in in vitro differentiated Th0, Th1, Th2, Th17 and Treg cells. (A) Naïve CD4 + T cells were cultured

Supplemental Figure 1. Signature gene expression in in vitro differentiated Th0, Th1, Th2, Th17 and Treg cells. (A) Naïve CD4 + T cells were cultured Supplemental Figure 1. Signature gene expression in in vitro differentiated Th0, Th1, Th2, Th17 and Treg cells. (A) Naïve CD4 + T cells were cultured under Th0, Th1, Th2, Th17, and Treg conditions. mrna

More information